Skip to content
PICO Portalanswers from OpenAlex

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

PaperCitations, authors & open-access status

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer have?

PICO Portalcitation count

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer has 3,676 citations in the OpenAlex counts PICO Portal stores.

When was Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer published?

PICO Portalyear

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer has 2018 year in the PICO Portal index.

What is the open-access status of Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer?

PICO Portaloa status

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer has bronze oa status in the PICO Portal index.

What is the DOI of Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer?

PICO Portaldoi

The DOI for Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer is on the source record.

What is the PMID of Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer?

PICO Portalpmid

The PMID for Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer is on the source record.

What is the OpenAlex record for Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer?

PICO Portalopenalex

The OpenAlex for Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial